{"id":"amoxicillin-short","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-5","effect":"Nausea"},{"rate":"1-3","effect":"Rash"},{"rate":"0.1-1","effect":"Allergic reaction / anaphylaxis"},{"rate":"1-3","effect":"Vomiting"}]},"_chembl":{"chemblId":"CHEMBL2105950","moleculeType":"Small molecule","molecularWeight":"387.39"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amoxicillin is a beta-lactam antibiotic that penetrates bacterial cell walls and irreversibly binds to penicillin-binding proteins, preventing the cross-linking of peptidoglycan strands. This disrupts cell wall integrity, leading to bacterial cell lysis and death. It is bactericidal and effective against a broad spectrum of gram-positive and some gram-negative bacteria.","oneSentence":"Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:10.149Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections including otitis media, sinusitis, respiratory tract infections, urinary tract infections, and skin infections"},{"name":"Helicobacter pylori eradication (as part of combination therapy)"}]},"trialDetails":[{"nctId":"NCT05761080","phase":"PHASE4","title":"Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-04-22","conditions":"Laparoscopic Appendectomy, Complicated Appendicitis, Periappendicular Abscess","enrollment":772},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT07352098","phase":"NA","title":"7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori","status":"NOT_YET_RECRUITING","sponsor":"Yueyue Li","startDate":"2026-02-01","conditions":"Helicobacter","enrollment":290},{"nctId":"NCT07275580","phase":"PHASE4","title":"Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-01-10","conditions":"Autoimmune Rheumatic Diseases, Tooth Extraction, Infection Prevention","enrollment":352},{"nctId":"NCT07104552","phase":"PHASE4","title":"Comparing Short to Standard Amoxicillin Course for Erysipelas","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-01-01","conditions":"Erysipelas","enrollment":656},{"nctId":"NCT07082465","phase":"","title":"Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2025-08-01","conditions":"Drug Resistance, Bacterial, Bacteremia","enrollment":108000},{"nctId":"NCT06303128","phase":"PHASE3","title":"Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge","status":"RECRUITING","sponsor":"James Tarbox, MD","startDate":"2024-02-03","conditions":"Penicillin Allergy","enrollment":380},{"nctId":"NCT04048304","phase":"NA","title":"Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial","status":"RECRUITING","sponsor":"Balgrist University Hospital","startDate":"2019-07-31","conditions":"Infection","enrollment":236},{"nctId":"NCT06200779","phase":"PHASE4","title":"Tailored Vs. Empirical Helicobacter Pylori Infection Treatment","status":"NOT_YET_RECRUITING","sponsor":"Manuel Coelho da Rocha","startDate":"2025-09","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT06125340","phase":"PHASE4","title":"Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy","status":"RECRUITING","sponsor":"Jeffrey","startDate":"2024-04-17","conditions":"Community-acquired Pneumonia","enrollment":75},{"nctId":"NCT05302531","phase":"PHASE1","title":"Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome","status":"RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2022-12-09","conditions":"Short Bowel Syndrome, Infection, Bacterial","enrollment":10},{"nctId":"NCT06168214","phase":"PHASE4","title":"Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2023-09-04","conditions":"the Eradication Rates of Helicobacter Pylori","enrollment":1404},{"nctId":"NCT04211649","phase":"PHASE4","title":"Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte)","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Center of Martinique","startDate":"2024-10-01","conditions":"Mild Leptospirosis","enrollment":220},{"nctId":"NCT06291012","phase":"PHASE4","title":"Stopping Pneumonia Antibiotherapy Regimen Early","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-09-01","conditions":"Community-acquired Pneumonia, Child, Only","enrollment":1100},{"nctId":"NCT05169554","phase":"PHASE2","title":"Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy","status":"RECRUITING","sponsor":"Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID)","startDate":"2021-12-01","conditions":"Buruli Ulcer","enrollment":140},{"nctId":"NCT06378502","phase":"PHASE4","title":"The Effect of Different Antibiotic Protocols on Peri-implant Tissue Health","status":"NOT_YET_RECRUITING","sponsor":"Universita degli Studi di Genova","startDate":"2024-05-03","conditions":"Antibiotic","enrollment":80},{"nctId":"NCT00917592","phase":"PHASE4","title":"Trial Assessing the Efficacy of a Short Course of Intravenous Antibiotic Followed by Oral Antibiotic in Uncomplicated Acute Diverticulitis","status":"COMPLETED","sponsor":"Consorci Sanitari de Terrassa","startDate":"2005-12","conditions":"Diverticulitis","enrollment":50},{"nctId":"NCT04400110","phase":"PHASE4","title":"Short Therapy for Febrile UTI in Childhood","status":"COMPLETED","sponsor":"IRCCS Burlo Garofolo","startDate":"2020-06-08","conditions":"Urinary Tract Infections","enrollment":154},{"nctId":"NCT05293977","phase":"NA","title":"Short-Term Use of Antibiotics and Adherence Level","status":"COMPLETED","sponsor":"Jordan University of Science and Technology","startDate":"2020-08-03","conditions":"Acute Infection","enrollment":589},{"nctId":"NCT02380352","phase":"PHASE4","title":"Short-course Antimicrobial Therapy for Paediatric Respiratory Infections","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2016-09","conditions":"Community-acquired Pneumonia","enrollment":281},{"nctId":"NCT02891915","phase":"PHASE4","title":"Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-02","conditions":"Pneumonia","enrollment":385},{"nctId":"NCT02795949","phase":"PHASE3","title":"Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2016-10","conditions":"Enterobacteriaceae Infections","enrollment":344},{"nctId":"NCT01166945","phase":"NA","title":"Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2010-11","conditions":"Sinusitis","enrollment":98},{"nctId":"NCT01676415","phase":"PHASE4","title":"Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2012-08","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":9},{"nctId":"NCT02830347","phase":"","title":"Changes in Resistome After Dental Extraction and Amoxicillin.","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2015-06","conditions":"Impacted Third Molar Tooth","enrollment":16},{"nctId":"NCT01511107","phase":"PHASE2","title":"Efficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on Resistance","status":"TERMINATED","sponsor":"Alejandro Hoberman","startDate":"2012-01","conditions":"Acute Otitis Media","enrollment":520},{"nctId":"NCT01963442","phase":"PHASE2","title":"Short Duration Treatment of Non-severe Community Acquired Pneumonia","status":"UNKNOWN","sponsor":"Versailles Hospital","startDate":"2013-11","conditions":"Community Acquired Pneumonia","enrollment":310},{"nctId":"NCT02764710","phase":"PHASE3","title":"Randomized Controlled Trial Comparing Long and Short Duration of Antibiotic Prophylaxis for Patients Undergoing Sinus Lift Surgery","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2016-05","conditions":"Maxillofacial Surgery","enrollment":250},{"nctId":"NCT02650518","phase":"PHASE2, PHASE3","title":"Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2015-12","conditions":"Catheter-Related Infections","enrollment":500},{"nctId":"NCT02143323","phase":"PHASE1","title":"A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI)","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2013-12","conditions":"Healthy","enrollment":32},{"nctId":"NCT00656747","phase":"PHASE4","title":"Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-03","conditions":"Chronic Bronchitis","enrollment":1372},{"nctId":"NCT02090738","phase":"PHASE2","title":"A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide","status":"WITHDRAWN","sponsor":"Yonsei University","startDate":"2014-03","conditions":"H. Pylori Infection","enrollment":""},{"nctId":"NCT01059123","phase":"PHASE4","title":"Short Course of Amoxicillin for Erysipelas","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-09","conditions":"Erysipelas","enrollment":10},{"nctId":"NCT01450241","phase":"NA","title":"Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia","status":"WITHDRAWN","sponsor":"Rabin Medical Center","startDate":"2012-01","conditions":"Febrile Neutropenia","enrollment":""},{"nctId":"NCT01575899","phase":"PHASE4","title":"Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori","status":"TERMINATED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2007-12","conditions":"Helicobacter Pylori Infection","enrollment":208},{"nctId":"NCT01096927","phase":"PHASE4","title":"Non Operative Treatment for Acute Appendicitis","status":"COMPLETED","sponsor":"Maggiore Bellaria Hospital, Bologna","startDate":"2010-01","conditions":"Lower Abdominal Pain, Right Iliac Fossa Pain, Acute Appendicitis","enrollment":160},{"nctId":"NCT00531791","phase":"PHASE3","title":"Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation","status":"COMPLETED","sponsor":"Laval University","startDate":"2007-11","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":14},{"nctId":"NCT00042718","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2001-11","conditions":"Bronchitis, Chronic Bronchitis","enrollment":659},{"nctId":"NCT00764062","phase":"PHASE4","title":"Amoxicillin Susceptibility of Oral Streptococci After a 3-Day or a 7-Day Amoxicillin Therapy","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2005-09","conditions":"Odontogenic Infection","enrollment":81},{"nctId":"NCT00407394","phase":"PHASE3","title":"Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze","status":"COMPLETED","sponsor":"King George's Medical University","startDate":"2004-04","conditions":"Non-Severe Pneumonia With Wheeze","enrollment":2000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":806,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Amoxicillin Short","genericName":"Amoxicillin Short","companyName":"Universita degli Studi di Genova","companyId":"universita-degli-studi-di-genova","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking. Used for Bacterial infections including otitis media, sinusitis, respiratory tract infections, urinary tract infections, and skin infections, Helicobacter pylori eradication (as part of combination therapy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}